Mimedx (MDXG) Amortization of Deferred Charges (2011 - 2026)

Mimedx (MDXG) has 15 years of Amortization of Deferred Charges data on file, last reported at $330000.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortization of Deferred Charges rose 7.49% year-over-year to $330000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 30.46% YoY), and the FY2025 full-year result was $1.3 million, down 3.66% from the prior year.
• Amortization of Deferred Charges improved to $330000.0 in Q1 2026, from $325000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $911000.0 in Q4 2022 to a low of $16000.0 in Q3 2024.
• A 5-year average of $309529.4 and a median of $317000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
• Across the five-year window, Amortization of Deferred Charges tumbled 85.59% in 2024 and jumped 1887.5% in 2025, its largest moves.
• Tracing MDXG's Amortization of Deferred Charges over 5 years: stood at $911000.0 in 2022, then dropped by 1.76% to $895000.0 in 2023, then plunged by 62.23% to $338000.0 in 2024, then declined by 3.85% to $325000.0 in 2025, then climbed by 1.54% to $330000.0 in 2026.
• Business Quant data shows MDXG's Amortization of Deferred Charges at $330000.0 in Q1 2026, $325000.0 in Q4 2025, and $318000.0 in Q3 2025.